Singular Health (ASX:SHG) — Material Events

ASX:SHG · 8 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 8 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
8
Singular Health Advances US Rollout Amid $2.97M Half-Year LossHigh
Singular Health reports $2.97M half-year loss; advances U.S. commercial rollout and gains FDA clearance for cloud platform
24 Feb 2026 ·Appendix 4D Half-year report ·85
Singular Health Expands US Footprint with FDA Clearance and Strategic Education DealsMedium
Singular Health advances U.S. deployments, secures FDA clearance, and expands education partnerships with strong financial position
28 Apr 2026 ·Quarterly Activities and Cash Flow Report ·85
Singular Health Advances FDA Bid with Cloud-Based 3DICOM MD UpgradeMedium
Singular Health submits FDA 510(k) for advanced 3DICOM MD Cloud medical imaging platform
28 Nov 2025 ·Regulatory Submission ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.

Market Mentions 3 - appeared in market wrap coverage

These are market wrap articles where Singular Health (ASX:SHG) was mentioned. They reflect broader market coverage, not company-specific announcements.

Market Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Wrap
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Wrap
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026
Wrap